Index RUT P/E - EPS (ttm) -4.71 Insider Own 10.38% Shs Outstand 77.20M Perf Week -2.31%
Market Cap 735.01M Forward P/E 4.63 EPS next Y 2.06 Insider Trans 56.23% Shs Float 69.23M Perf Month 12.47%
Income -362.69M PEG - EPS next Q 0.20 Inst Own 100.68% Short Float 6.98% Perf Quarter -30.19%
Sales 10.70B P/S 0.07 EPS this Y 12.73% Inst Trans -1.17% Short Ratio 3.27 Perf Half Y -33.88%
Book/sh 7.32 P/B 1.30 EPS next Y 19.19% ROA -7.44% Short Interest 4.83M Perf Year -62.89%
Cash/sh 0.64 P/C 14.88 EPS next 5Y 16.60% ROE -48.70% 52W Range 6.07 - 28.35 Perf YTD -27.20%
Dividend Est. - P/FCF - EPS past 5Y -35.63% ROI -13.64% 52W High -66.44% Beta 0.99
Dividend TTM - Quick Ratio 0.47 Sales past 5Y 3.31% Gross Margin 18.26% 52W Low 56.75% ATR (14) 0.69
Dividend Ex-Date Dec 14, 2021 Current Ratio 1.08 EPS Y/Y TTM -757.75% Oper. Margin 2.44% RSI (14) 51.01 Volatility 5.29% 7.53%
Employees 23200 Debt/Eq 3.95 Sales Y/Y TTM 3.55% Profit Margin -3.39% Recom 2.83 Target Price 11.10
Option/Short Yes / Yes LT Debt/Eq 3.71 EPS Q/Q -1777.83% Payout - Rel Volume 0.53 Prev Close 9.54
Sales Surprise 0.44% EPS Surprise 5.67% Sales Q/Q 1.50% Earnings Feb 28 BMO Avg Volume 1.48M Price 9.52
SMA20 16.00% SMA50 -13.87% SMA200 -30.89% Trades
Volume 745,688 Change -0.26%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-19-24 Upgrade Citigroup
Neutral → Buy
$24 → $19
Feb-26-24 Initiated Leerink Partners
Market Perform
$24
Jan-03-24 Initiated Barclays
Equal Weight
$21
Oct-13-22 Downgrade Citigroup
Buy → Neutral
$52 → $18
Oct-12-22 Downgrade Robert W. Baird
Outperform → Neutral
$62 → $22
Oct-12-22 Downgrade BofA Securities
Buy → Underperform
$43 → $17
Apr-26-22 Resumed Citigroup
Buy
$55
Apr-01-22 Resumed Credit Suisse
Neutral
$43
Mar-30-22 Resumed JP Morgan
Underweight
$46
Dec-17-20 Upgrade UBS
Neutral → Buy
$27 → $37
Sep-25-20 Upgrade Barclays
Underweight → Equal Weight
$20
Jul-21-20 Upgrade Robert W. Baird
Neutral → Outperform
$8 → $14
Jul-21-20 Upgrade BofA Securities
Neutral → Buy
$8 → $12
May-05-20 Downgrade Robert W. Baird
Outperform → Neutral
$8
Apr-23-20 Resumed Credit Suisse
Neutral
$8
Jan-21-20 Upgrade Robert W. Baird
Neutral → Outperform
$9
Sep-06-19 Reiterated BofA/Merrill
Neutral
$4 → $7.50
Apr-10-19 Reiterated BofA/Merrill
Neutral
$7 → $4.50
Jan-17-19 Initiated UBS
Neutral
$8
Nov-01-18 Reiterated Barclays
Underweight
$12 → $8
Show Previous Ratings
Mar-01-25 02:06AM
Feb-28-25 11:59PM
(Thomson Reuters StreetEvents) +39.04%
01:50PM
07:40AM
07:19AM
06:49AM
Loading…
06:49AM
(Associated Press Finance)
06:30AM
Feb-27-25 10:06AM
08:02AM
07:20AM
Feb-21-25 10:00AM
Feb-14-25 04:09AM
Feb-11-25 06:30AM
Feb-07-25 12:10PM
Feb-06-25 08:53AM
04:36AM
Loading…
Feb-04-25 04:36AM
Feb-03-25 08:09AM
06:30AM
Dec-02-24 04:15PM
04:15PM
Nov-22-24 08:42AM
Nov-07-24 01:00AM
Nov-06-24 06:25AM
Nov-05-24 06:57AM
02:03AM
01:26AM
(Thomson Reuters StreetEvents)
Nov-04-24 10:21AM
07:40AM
06:37AM
(Associated Press Finance)
06:30AM
09:05AM
Loading…
Nov-01-24 09:05AM
Oct-21-24 04:05PM
Sep-23-24 06:45AM
Sep-10-24 06:45AM
Sep-09-24 06:30AM
Aug-26-24 07:01PM
Aug-19-24 09:00PM
Aug-05-24 09:00PM
Aug-03-24 06:03AM
(Thomson Reuters StreetEvents)
Aug-02-24 08:54AM
07:40AM
06:43AM
(Associated Press Finance)
06:30AM
Jul-27-24 09:00PM
Jul-26-24 12:10PM
10:00AM
09:55AM
Jul-25-24 06:55AM
Jul-24-24 05:13AM
Jul-23-24 06:31AM
06:30AM
Jul-21-24 12:45AM
Jul-19-24 09:00PM
Jun-08-24 03:19AM
Jun-07-24 03:02AM
Jun-06-24 03:00AM
Jun-05-24 02:36AM
May-28-24 04:00PM
May-13-24 06:30AM
May-06-24 09:40AM
09:13AM
May-04-24 08:28AM
03:01AM
May-03-24 10:41PM
(Thomson Reuters StreetEvents) -25.70%
+5.55%
04:08PM
02:56PM
10:53AM
09:30AM
09:13AM
07:51AM
06:41AM
(Associated Press Finance)
06:30AM
Apr-30-24 11:03AM
Apr-22-24 06:30AM
Apr-13-24 12:18PM
Apr-02-24 10:28AM
Mar-04-24 01:35PM
Feb-26-24 09:15AM
Feb-23-24 09:40AM
Feb-21-24 08:39AM
Feb-20-24 10:44PM
(Thomson Reuters StreetEvents)
03:00PM
07:40AM
07:04AM
06:51AM
06:48AM
(Associated Press Finance)
06:30AM
Feb-08-24 04:15PM
Jan-17-24 09:40AM
Dec-07-23 06:45AM
Dec-06-23 07:00AM
Nov-29-23 06:30AM
Nov-23-23 03:03AM
Nov-13-23 11:03PM
Nov-03-23 09:24PM
(Thomson Reuters StreetEvents) +27.08%
08:45AM
08:14AM
06:07AM
(Associated Press Finance)
06:00AM
Oct-24-23 04:30PM
Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segment includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Henrico County, VA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Coliseum Capital Management, L 10% Owner Feb 28 '25 Buy 9.39 1,738,511 16,324,618 9,469,698 Mar 04 09:07 PM Coliseum Capital Management, L 10% Owner Mar 04 '25 Buy 9.75 800,000 7,800,000 10,624,599 Mar 04 09:07 PM Coliseum Capital Management, L 10% Owner Mar 03 '25 Buy 9.19 354,901 3,261,540 9,824,599 Mar 04 09:07 PM Leon Jonathan A EVP, Chief Financial Officer Nov 21 '24 Sale 11.82 5,282 62,433 130,822 Nov 25 08:15 AM Leon Jonathan A Officer Nov 21 '24 Proposed Sale 11.82 5,282 62,433 Nov 21 10:16 AM Sarkar Snehashish Chief Information Officer Nov 18 '24 Sale 12.26 2,055 25,194 55,886 Nov 19 05:11 PM Sarkar Snehashish Officer Nov 18 '24 Proposed Sale 12.26 2,055 25,194 Nov 18 11:24 AM Bruni Alexander J Former Officer Sep 20 '24 Proposed Sale 15.93 3,384 53,921 Sep 20 01:06 PM Leon Jonathan A SVP, Corp Treasurer, Intm CFO Aug 22 '24 Sale 15.83 7,500 118,725 93,171 Aug 26 04:14 PM Leon Jonathan A Officer Aug 22 '24 Proposed Sale 15.83 7,500 118,725 Aug 22 10:29 AM Bruni Alexander J Former Officer Aug 16 '24 Proposed Sale 16.00 635 10,160 Aug 16 11:07 AM Bernocchi Perry A EVP, CEO,. Patient Direct Jun 06 '24 Sale 17.49 20,015 350,003 129,520 Jun 07 04:49 PM Beck Mark A Director Jun 05 '24 Sale 17.25 9,344 161,184 11,154 Jun 06 04:10 PM Sarkar Snehashish EVP, Chief Information Officer Jun 04 '24 Sale 17.32 9,980 172,854 59,137 Jun 05 04:04 PM Bruni Alexander J EVP, CFO Jun 03 '24 Sale 17.76 10,568 187,688 49,950 Jun 04 06:07 PM Galloway Heath H EVP,General Counsel & CorpSecy May 16 '24 Sale 20.18 2,031 40,986 56,898 May 20 08:11 AM Galloway Heath H EVP,General Counsel & CorpSecy May 17 '24 Sale 19.06 2,052 39,111 54,846 May 20 08:11 AM Bernocchi Perry A EVP, CEO,. Patient Direct May 01 '24 Sale 24.31 24,094 585,680 170,497 May 03 04:03 PM Leon Jonathan A SVP, Corporate Treasurer Apr 22 '24 Sale 24.84 5,000 124,200 84,673 Apr 23 06:00 PM
Index RUT P/E 20.09 EPS (ttm) 1.55 Insider Own 11.74% Shs Outstand 88.45M Perf Week 0.03%
Market Cap 2.76B Forward P/E 13.18 EPS next Y 2.36 Insider Trans -0.02% Shs Float 78.08M Perf Month 0.45%
Income 138.78M PEG 6.59 EPS next Q 0.90 Inst Own 86.92% Short Float 2.59% Perf Quarter 35.91%
Sales 6.51B P/S 0.42 EPS this Y -6.37% Inst Trans -8.59% Short Ratio 1.45 Perf Half Y 52.10%
Book/sh 11.19 P/B 2.78 EPS next Y 9.72% ROA 4.81% Short Interest 2.02M Perf Year 14.65%
Cash/sh 1.53 P/C 20.41 EPS next 5Y 3.05% ROE 14.15% 52W Range 19.45 - 31.79 Perf YTD 0.94%
Dividend Est. 1.04 (3.35%) P/FCF - EPS past 5Y 17.28% ROI 9.85% 52W High -2.01% Beta 0.71
Dividend TTM 0.78 (2.50%) Quick Ratio 0.73 Sales past 5Y 3.43% Gross Margin 20.57% 52W Low 60.17% ATR (14) 0.06
Dividend Ex-Date Oct 18, 2024 Current Ratio 1.41 EPS Y/Y TTM -23.40% Oper. Margin 3.44% RSI (14) 73.11 Volatility 0.13% 0.13%
Employees 7600 Debt/Eq 0.88 Sales Y/Y TTM -0.85% Profit Margin 2.13% Recom 3.00 Target Price 30.42
Option/Short Yes / Yes LT Debt/Eq 0.42 EPS Q/Q -31.94% Payout 52.40% Rel Volume 1.80 Prev Close 31.16
Sales Surprise -3.70% EPS Surprise -30.68% Sales Q/Q -2.70% Earnings Feb 26 AMC Avg Volume 1.39M Price 31.15
SMA20 0.17% SMA50 0.51% SMA200 23.28% Trades
Volume 2,380,505 Change -0.03%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-04-24 Initiated Mizuho
Neutral
$23
Feb-29-24 Downgrade Piper Sandler
Overweight → Neutral
$34 → $28
Feb-26-24 Initiated Leerink Partners
Outperform
$36
May-13-22 Resumed Credit Suisse
Outperform
$36
Jan-31-22 Initiated Morgan Stanley
Equal-Weight
$30
Oct-01-21 Resumed Credit Suisse
Outperform
$38
Jun-17-21 Upgrade Piper Sandler
Neutral → Overweight
$34 → $44
Nov-10-20 Downgrade Guggenheim
Buy → Neutral
Jul-07-20 Resumed Piper Sandler
Neutral
$22
Jun-25-20 Upgrade Goldman
Sell → Neutral
$11 → $21
Apr-02-20 Upgrade Wolfe Research
Underperform → Peer Perform
Feb-28-20 Upgrade JP Morgan
Underweight → Neutral
$20 → $25
Feb-27-20 Upgrade BofA/Merrill
Neutral → Buy
Jan-09-20 Upgrade BofA/Merrill
Underperform → Neutral
$19.50 → $22.50
Jan-07-20 Upgrade Guggenheim
Neutral → Buy
$25
Dec-18-19 Upgrade CFRA
Strong Sell → Hold
May-30-19 Initiated Wolfe Research
Underperform
Apr-18-19 Initiated Guggenheim
Neutral
Jan-17-19 Initiated UBS
Neutral
$23
Jan-03-19 Upgrade Evercore ISI
Underperform → In-line
Show Previous Ratings
Today 12:45PM
11:30AM
Feb-26-25 04:30PM
Feb-14-25 04:08AM
Jan-21-25 05:00PM
08:40AM
Loading…
Jan-14-25 08:40AM
Dec-15-24 10:00AM
Dec-12-24 02:32PM
Dec-11-24 04:10PM
(Investor's Business Daily) +35.87%
02:09PM
11:52AM
11:20AM
10:18AM
08:10AM
08:04AM
(The Wall Street Journal)
07:32AM
Loading…
07:32AM
07:00AM
Dec-10-24 09:00AM
Dec-06-24 02:30AM
(Thomson Reuters StreetEvents)
02:00AM
Dec-05-24 07:00AM
Nov-27-24 07:19PM
Nov-13-24 07:00AM
Nov-07-24 08:37AM
Oct-23-24 06:00AM
Oct-21-24 08:40AM
Sep-27-24 11:30AM
Sep-26-24 06:00AM
Sep-17-24 04:30PM
Aug-28-24 11:03PM
(Thomson Reuters StreetEvents) -12.51%
11:59AM
Loading…
11:59AM
07:18AM
07:00AM
Aug-26-24 06:12AM
Aug-23-24 09:45AM
Aug-21-24 06:02PM
Aug-12-24 07:00AM
Aug-09-24 09:15AM
Jul-19-24 10:34AM
Jul-18-24 10:00AM
Jul-15-24 01:44PM
Jul-09-24 04:05PM
Jun-20-24 08:01AM
08:01AM
Jun-19-24 12:54AM
(Thomson Reuters StreetEvents)
Jun-18-24 11:53AM
09:30AM
08:10AM
07:00AM
Jun-14-24 09:15AM
07:35AM
Jun-13-24 11:37AM
Jun-12-24 04:30PM
10:00AM
Jun-11-24 04:30PM
Jun-03-24 11:56AM
May-23-24 09:01AM
May-10-24 07:00AM
Apr-10-24 01:22PM
Mar-27-24 01:57PM
Mar-22-24 09:23AM
Mar-11-24 08:04PM
Mar-01-24 08:06PM
Feb-29-24 11:44AM
09:00AM
Feb-28-24 09:30AM
07:00AM
Feb-26-24 11:38AM
Feb-21-24 06:12PM
Feb-02-24 08:00AM
Jan-17-24 05:12AM
Jan-16-24 02:43PM
Jan-03-24 08:41AM
(Investor's Business Daily)
Jan-02-24 06:21PM
Dec-29-23 11:30AM
Dec-06-23 04:30PM
Dec-01-23 09:49AM
08:59AM
Nov-30-23 04:10AM
Nov-29-23 10:22PM
(Thomson Reuters StreetEvents) -17.24%
10:16AM
08:50AM
07:11AM
07:00AM
Nov-27-23 06:05AM
Nov-22-23 08:28AM
Nov-21-23 04:30PM
Nov-20-23 04:29PM
Nov-17-23 09:40AM
Nov-06-23 12:18PM
08:44AM
Nov-03-23 09:50AM
Nov-02-23 09:40AM
Oct-29-23 05:35PM
Oct-25-23 05:20AM
Oct-18-23 07:07AM
Oct-13-23 11:36AM
Oct-09-23 09:50AM
Oct-04-23 08:08PM
Sep-29-23 11:30AM
Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Zurbay Donald President & CEO Dec 09 '24 Sale 23.08 1,962 45,278 222,736 Dec 09 06:00 PM Zurbay Donald President & CEO Jul 16 '24 Sale 24.99 7,216 180,328 230,072 Jul 16 04:38 PM Zurbay Donald President & CEO Jul 03 '24 Sale 23.71 5,875 139,322 237,288 Jul 08 10:53 AM KORSH LES B CLO & Corporate Secretary Jul 03 '24 Sale 23.71 2,842 67,398 103,765 Jul 08 10:50 AM BARRY KEVIN MICHAEL CFO Jul 03 '24 Sale 23.72 1,216 28,846 41,605 Jul 08 10:47 AM BERGESON SAMANTHA L CHRO Jul 03 '24 Sale 23.87 254 6,063 20,578 Jul 08 10:43 AM
Index S&P 500 P/E 23.16 EPS (ttm) 3.05 Insider Own 1.42% Shs Outstand 124.16M Perf Week -1.07%
Market Cap 8.78B Forward P/E 13.31 EPS next Y 5.31 Insider Trans -0.85% Shs Float 122.42M Perf Month -10.40%
Income 390.00M PEG 2.99 EPS next Q 1.13 Inst Own 105.09% Short Float 4.74% Perf Quarter -3.16%
Sales 12.67B P/S 0.69 EPS this Y 2.93% Inst Trans -1.44% Short Ratio 3.07 Perf Half Y 2.62%
Book/sh 27.33 P/B 2.59 EPS next Y 8.82% ROA 3.75% Short Interest 5.80M Perf Year -5.44%
Cash/sh 0.98 P/C 71.95 EPS next 5Y 7.75% ROE 11.07% 52W Range 63.67 - 82.49 Perf YTD 2.16%
Dividend Est. - P/FCF 12.54 EPS past 5Y -2.15% ROI 7.11% 52W High -14.30% Beta 0.81
Dividend TTM - Quick Ratio 0.78 Sales past 5Y 5.23% Gross Margin 29.71% 52W Low 11.03% ATR (14) 2.47
Dividend Ex-Date - Current Ratio 1.42 EPS Y/Y TTM -3.26% Oper. Margin 5.77% RSI (14) 38.41 Volatility 4.48% 3.18%
Employees 25000 Debt/Eq 0.85 Sales Y/Y TTM 2.71% Profit Margin 3.08% Recom 2.44 Target Price 80.23
Option/Short Yes / Yes LT Debt/Eq 0.62 EPS Q/Q 443.36% Payout 0.00% Rel Volume 0.52 Prev Close 72.92
Sales Surprise -2.85% EPS Surprise -1.18% Sales Q/Q 5.77% Earnings Feb 25 BMO Avg Volume 1.89M Price 70.69
SMA20 -5.18% SMA50 -5.20% SMA200 -0.77% Trades
Volume 933,909 Change -3.05%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-14-25 Initiated Wells Fargo
Equal Weight
$80
Jan-06-25 Upgrade BofA Securities
Underperform → Buy
$69 → $84
Dec-04-24 Initiated Mizuho
Neutral
$75
Jul-22-24 Upgrade Robert W. Baird
Neutral → Outperform
$81 → $92
Feb-26-24 Initiated Leerink Partners
Market Perform
$78
Dec-12-23 Upgrade JP Morgan
Neutral → Overweight
$71 → $82
Nov-10-23 Upgrade Stifel
Hold → Buy
$70
Aug-08-22 Upgrade UBS
Sell → Neutral
$80
Jul-21-22 Downgrade Goldman
Buy → Neutral
$93 → $85
Jun-14-22 Downgrade Robert W. Baird
Outperform → Neutral
$103 → $88
May-13-22 Resumed Credit Suisse
Outperform
$100
Jan-31-22 Initiated Morgan Stanley
Underweight
$67
Jan-07-22 Upgrade Credit Suisse
Neutral → Outperform
$78 → $90
Oct-01-21 Resumed Credit Suisse
Neutral
$78
Feb-08-21 Resumed Piper Sandler
Overweight
$83
Jan-04-21 Upgrade Robert W. Baird
Neutral → Outperform
$70 → $79
Nov-03-20 Upgrade Barrington Research
Mkt Perform → Outperform
$72
May-06-20 Downgrade Barrington Research
Outperform → Mkt Perform
Apr-07-20 Upgrade Goldman
Neutral → Buy
$64 → $59
Apr-02-20 Upgrade Wolfe Research
Peer Perform → Outperform
$68
Show Previous Ratings
Today 11:30AM
06:30AM
Mar-11-25 06:30AM
Mar-10-25 05:03AM
Mar-04-25 08:06AM
04:01AM
Loading…
04:01AM
Mar-03-25 06:30AM
Feb-26-25 06:30AM
02:03AM
12:06AM
(Thomson Reuters StreetEvents)
Feb-25-25 07:10AM
06:21AM
06:17AM
(Associated Press Finance)
06:00AM
Feb-24-25 08:04AM
09:15AM
Loading…
Feb-20-25 09:15AM
Feb-14-25 04:08AM
Feb-12-25 06:30AM
Feb-10-25 06:30AM
Feb-05-25 09:00AM
Jan-29-25 10:31AM
09:04AM
(The Wall Street Journal)
08:04AM
07:00AM
05:45AM
Jan-23-25 06:30AM
Jan-22-25 04:37PM
Jan-16-25 06:42AM
Jan-15-25 06:30AM
Jan-14-25 09:25AM
06:30AM
Loading…
Jan-09-25 06:30AM
Jan-07-25 12:03PM
Dec-26-24 09:00PM
(The Wall Street Journal)
Dec-17-24 06:30AM
Dec-13-24 09:40AM
Dec-12-24 02:32PM
Dec-05-24 11:30AM
Nov-26-24 09:40AM
Nov-23-24 05:00AM
Nov-21-24 06:30AM
03:59AM
Nov-20-24 06:30AM
Nov-18-24 04:51PM
01:35PM
Nov-16-24 10:12AM
Nov-06-24 02:15AM
01:46AM
(Thomson Reuters StreetEvents)
Nov-05-24 12:11PM
09:30AM
07:11AM
07:10AM
06:10AM
(Associated Press Finance)
06:00AM
Oct-31-24 01:23PM
09:15AM
Oct-29-24 10:01AM
Oct-24-24 06:30AM
Oct-18-24 12:10PM
Oct-17-24 08:00AM
Oct-08-24 05:33PM
Oct-02-24 04:32PM
Oct-01-24 11:00AM
06:30AM
Sep-30-24 06:30AM
Sep-26-24 03:00PM
06:30AM
Sep-25-24 07:30AM
06:27AM
Sep-17-24 06:30AM
Sep-12-24 06:30AM
Sep-05-24 11:31AM
07:58AM
Aug-29-24 06:30AM
Aug-23-24 11:35AM
Aug-19-24 09:00AM
08:25AM
Aug-15-24 06:30AM
Aug-12-24 06:30AM
Aug-07-24 06:32AM
03:04AM
(Thomson Reuters StreetEvents)
Aug-06-24 05:32PM
09:43AM
09:30AM
08:57AM
07:10AM
06:11AM
(Associated Press Finance)
06:00AM
Aug-05-24 09:16AM
09:05AM
Jul-31-24 06:30AM
Jul-30-24 10:01AM
Jul-26-24 09:50AM
Jul-23-24 09:59AM
Jul-22-24 09:40AM
Jul-18-24 03:33AM
Jul-17-24 05:41PM
Jul-15-24 03:57AM
Jul-12-24 09:33AM
Jul-10-24 04:00PM
Jul-08-24 06:30AM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
KUEHN KURT P Director Mar 05 '25 Sale 71.55 2,787 199,396 15,687 Mar 06 04:31 PM KUEHN KURT P Director Mar 05 '25 Proposed Sale 71.55 2,787 199,396 Mar 05 04:45 PM Ettinger Michael S EVP & Chief Operating Officer Nov 18 '24 Sale 75.00 12,240 918,000 87,706 Nov 20 04:15 PM Ettinger Michael S Officer Nov 18 '24 Proposed Sale 75.00 12,240 918,000 Nov 18 03:05 PM McGlynn Lorelei SVP, Chief Human Res. Officer Sep 06 '24 Sale 69.30 21,035 1,457,726 71,833 Sep 09 05:19 PM McGlynn Lorelei Officer Sep 06 '24 Proposed Sale 69.93 21,035 1,470,998 Sep 06 11:38 AM MLOTEK MARK E EVP, Chief Strategic Officer Aug 14 '24 Sale 69.12 3,000 207,360 87,851 Aug 15 04:36 PM MLOTEK MARK E Officer Aug 14 '24 Proposed Sale 69.12 3,000 207,353 Aug 14 12:27 PM Siegel Walter Sr. VP & Chief Legal Officer Jun 06 '24 Sale 69.47 4,134 287,189 39,526 Jun 07 04:15 PM Connett Bradford C CEO, NA Distribution Group Mar 20 '24 Sale 74.28 6,430 477,620 73,108 Mar 21 04:18 PM BRESLAWSKI JAMES P Vice Chairman, President Mar 18 '24 Sale 74.37 2,907 216,194 209,562 Mar 19 04:11 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
